文献速递生殖医学

严重弱精伴精子鞭毛多发形态异常(MMAF)的遗传诊断、精子表型与ICSI结局

Genetic diagnosis, sperm phenotype and ICSI outcome in case of severe asthenozoospermia with multiple morphological abnormalities of the flagellum.
PubMed 文献 · Hum Reprod · 2021-01-01

该回顾性研究纳入25例严重弱精伴MMAF表型的不育男性,行透射电镜和全外显子测序,并对20对夫妇的40个ICSI周期与378例非MMAF的OAT对照比较。MMAF组受精率65.7%与非MMAF组66.0%无统计学差异,临床妊娠率每移植23.3%对37.1%亦无显著差异,20对中7对获活产共11名婴儿无出生缺陷。

要点

  • MMAF患者ICSI受精率65.7%与非MMAF对照66.0%无统计学差异。
  • 每移植临床妊娠率MMAF组23.3%,非MMAF组37.1%,无显著差异。
  • 20对MMAF夫妇中7对经ICSI获活产,共11名婴儿无出生缺陷。

核心结论

  • 尽管偶有技术困难,MMAF夫妇的ICSI结局与需要ICSI的其他夫妇无差异,与遗传缺陷无关。

研究设计与样本

  • 回顾性研究,2009至2017年法国巴黎学术生殖中心招募25例严重弱精伴MMAF表型不育男性。
  • 对25例中24例行全外显子测序,对精子行透射电镜超微结构分析。
  • 20对MMAF夫妇接受ICSI共40个周期,对照为378例无MMAF的OAT男性。

主要发现

  • 透射电镜显示轴丝中央微管对缺失是最主要异常,频率显著高于对照精子(P < 0.01)。
  • 24例测序中13例(54.2%)发现CFAP43、CFAP44、CFAP69、DNAH1、DNAH8、AK7、TTC29和MAATS1的纯合或复合杂合致病突变。
  • 40个ICSI周期中13个周期(5对夫妇)因绝对弱精需行低渗膨胀(HOS)试验。
  • 受精率MMAF组65.7%与非MMAF组66.0%无统计学差异,且不随基因型、鞭毛表型或HOS试验使用而变化。
  • 每移植临床妊娠率MMAF组23.3%与非MMAF组37.1%无显著差异;20对中7对获活产,11名婴儿无出生缺陷。

关键数值与推荐

  • MMAF表型依据精子前向运动降低及缺失、短、卷曲或不规则鞭毛频率增加判定。
  • 受精率MMAF组65.7%,非MMAF组66.0%,无统计学差异。
  • 每移植临床妊娠率MMAF组23.3%,非MMAF组37.1%,无显著差异。
  • 轴丝中央微管对缺失频率显著高于对照精子(P < 0.01)。
  • 13/24例(54.2%)检出致病突变,其中11例累及MMAF基因、2例累及原发性纤毛运动障碍(PCD)相关基因。

临床怎么用

  • 对因严重弱精需ICSI的男性应考虑早期全面的表型和遗传评估。
  • MMAF表型并非ICSI的禁忌,其受精和妊娠结局与无MMAF的OAT夫妇相当。
  • 绝对弱精者可行HOS试验辅助ICSI,本研究未见其影响受精率。

局限性

  • ICSI结局为回顾性评估且样本量小,需更大队列确认。
  • 因精子浓度低,部分患者未能完成透射电镜分析。
  • 全外显子测序结果尚未覆盖全部纳入男性。
  • 不能排除某些罕见遗传病因可能导致低受精率或低妊娠率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are ICSI outcomes impaired in cases of severe asthenozoospermia with multiple morphological abnormalities of the flagellum (MMAF phenotype)? SUMMARY ANSWER: Despite occasional technical difficulties, ICSI outcomes for couples with MMAF do not differ from those of other couples requiring ICSI, irrespective of the genetic defect. WHAT IS KNOWN ALREADY: Severe asthenozoospermia, especially when associated with the MMAF phenotype, results in male infertility. Recent findings have confirmed that a genetic aetiology is frequently responsible for this phenotype. In such situations, pregnancies can be achieved using ICSI. However, few studies to date have provided detailed analyses regarding the flagellar ultrastructural defects underlying this phenotype, its genetic aetiologies, and the results of ICSI in such cases of male infertility. STUDY DESIGN, SIZE, DURATION: We performed a retrospective study of 25 infertile men exhibiting severe asthenozoospermia associated with the MMAF phenotype identified through standard semen analysis. They were recruited at an academic centre for assisted reproduction in Paris (France) between 2009 and 2017. Transmission electron microscopy (TEM) and whole exome sequencing (WES) were performed in order to determine the sperm ultrastructural phenotype and the causal mutations, respectively. Finally 20 couples with MMAF were treated by assisted reproductive technologies based on ICSI. PARTICIPANTS/MATERIALS, SETTING, METHODS: Patients with MMAF were recruited based on reduced sperm progressive motility and increased frequencies of absent, short, coiled or irregular flagella compared with those in sperm from fertile control men. A quantitative analysis of the several ultrastructural defects was performed for the MMAF patients and for fertile men. The ICSI results obtained for 20 couples with MMAF were compared to those of 378 men with oligoasthenoteratozoospermia but no MMAF as an ICSI control group. MAIN RESULTS AND THE ROLE OF CHANCE: TEM analysis and categorisation of the flagellar anomalies found in these patients provided important information regarding the structural defects underlying asthenozoospermia and sperm tail abnormalities. In particular, the absence of the central pair of axonemal microtubules was the predominant anomaly observed more frequently than in control sperm (P < 0.01). Exome sequencing, performed for 24 of the 25 patients, identified homozygous or compound heterozygous pathogenic mutations in CFAP43, CFAP44, CFAP69, DNAH1, DNAH8, AK7, TTC29 and MAATS1 in 13 patients (54.2%) (11 affecting MMAF genes and 2 affecting primary ciliary dyskinesia (PCD)-associated genes). A total of 40 ICSI cycles were undertaken for 20 MMAF couples, including 13 cycles (for 5 couples) where a hypo-osmotic swelling (HOS) test was required due to absolute asthenozoospermia. The fertilisation rate was not statistically different between the MMAF (65.7%) and the non-MMAF (66.0%) couples and it did not differ according to the genotype or the flagellar phenotype of the subjects or use of the HOS test. The clinical pregnancy rate per embryo transfer did not differ significantly between the MMAF (23.3%) and the non-MMAF (37.1%) groups. To date, 7 of the 20 MMAF couples have achieved a live birth from the ICSI attempts, with 11 babies born without any birth defects. LIMITATIONS, REASONS FOR CAUTION: The ICSI procedure outcomes were assessed retrospectively on a small number of affected subjects and should be confirmed on a larger cohort. Moreover, TEM analysis could not be performed for all patients due to low sperm concentrations, and WES results are not yet available for all of the included men. WIDER IMPLICATIONS OF THE FINDINGS: An early and extensive phenotypic and genetic investigation should be considered for all men requiring ICSI for severe asthenozoospermia. Although our study did not reveal any adverse ICSI outcomes associated with MMAF, we cannot rule out that some rare genetic causes could result in low fertilisation or pregnancy rates. STUDY FUNDING/COMPETING INTEREST(S): No external funding was used for this study and there are no competing interests. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ferreux L, Bourdon M, Chargui A, et al. Genetic diagnosis, sperm phenotype and ICSI outcome in case of severe asthenozoospermia with multiple morphological abnormalities of the flagellum. Hum Reprod. 2021. PMID: 34529793. doi:10.1093/humrep/deab200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。